Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Paola Di FioreFabio Frediani

Abstract

Since chronic migraine is difficult to treat and often associated with medication overuse, non-invasive neurostimulation approaches are worth investigating. Transcutaneous supraorbital neurostimulation using the Cefaly®device is promising as a non-invasive preventive treatment for episodic migraine, but no data are available for chronic migraine. Our aim was to perform a preliminary evaluation of the efficacy of the Cefaly®device for the prophylaxis of chronic migraine with or without medication overuse. Primary endpoints were 50% reduction in monthly migraine days and 50% reduction in monthly medication use over 4 months. In an open-label study, twenty-three consecutive headache center patients with chronic migraine, diagnosed according to International Headache Society criteria, were recruited prospectively. After informed consent, patients were trained to use Cefaly®and instructed to use it for 20 min daily over 4 months. All patients received active neurostimulation. Thirty-five percent of the patients enrolled in the study achieved the study endpoints. Over half the patients had a greater than 50% reduction in acute medication consumption.

References

Aug 30, 2003·Current Pain and Headache Reports·T Bartsch, Peter J Goadsby
Sep 27, 2003·Cephalalgia : an International Journal of Headache·M SilvestriniL Provinciali
Nov 11, 2003·Brain : a Journal of Neurology·Manjit S MatharuPeter J Goadsby
Dec 25, 2003·Neurology·Paul J SpiraUNKNOWN Australian Gabapentin Chronic Daily Headache Group
Apr 28, 2004·Headache·Frederick G FreitagUNKNOWN US Headache Guidelines Consortium, Section on Inpatient Treatment Chairpersons
May 25, 2004·Cephalalgia : an International Journal of Headache·M E BigalR B Lipton
Dec 21, 2004·Cephalalgia : an International Journal of Headache·Z KatsaravaV Limmroth
Sep 9, 2006·Clinical Neuropharmacology·Daniele MeiGirolamo Di Trapani
Sep 12, 2006·Cephalalgia : an International Journal of Headache·P ZeebergR Jensen
Feb 16, 2007·Headache·Stephen D SilbersteinUNKNOWN Topiramate Chronic Migraine Study Group
Apr 20, 2007·Cephalalgia : an International Journal of Headache·H-C DienerUNKNOWN TOPMAT-MIG-201(TOP-CHROME) Study Group
Jan 31, 2008·The Journal of Headache and Pain·Vedat Ali YurekliFatih Gultekin
Jul 17, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Domenico D'AmicoGennaro Bussone
Apr 22, 2009·Current Opinion in Neurology·Marcelo E Bigal, Richard B Lipton
May 13, 2009·Current Opinion in Neurology·Thorsten BartschPeter J Goadsby
Jul 21, 2009·Cephalalgia : an International Journal of Headache·J L NatoliR B Lipton
Mar 20, 2010·Lancet Neurology·Stefan Evers, Martin Marziniak
May 22, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Domenico D'Amico
Jul 22, 2010·Cephalalgia : an International Journal of Headache·S K AuroraUNKNOWN PREEMPT 1 Chronic Migraine Study Group
Jul 22, 2010·Cephalalgia : an International Journal of Headache·H C DienerUNKNOWN PREEMPT 2 Chronic Migraine Study Group
Sep 24, 2010·Cephalalgia : an International Journal of Headache·Joel R SaperUNKNOWN ONSTIM Investigators
Nov 11, 2010·Current Pain and Headache Reports·Aubrey N ManackRichard B Lipton
May 6, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Domenico D'AmicoG Bussone
May 1, 2012·Current Opinion in Neurology·Delphine MagisJean Schoenen
Jul 21, 2012·Lancet Neurology·Delphine Magis, Jean Schoenen
May 15, 2013·Cephalalgia : an International Journal of Headache·Tim P Jürgens, Massimo Leone
Jun 19, 2013·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification Committee of the International Headache Society (IHS)
May 29, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giorgio Lambru, Manjit Singh Matharu

❮ Previous
Next ❯

Citations

Mar 31, 2018·Current Opinion in Neurology·Amaal Starling
Jun 14, 2018·Expert Review of Neurotherapeutics·Jean Schoenen, Gianluca Coppola
Aug 25, 2018·Cephalalgia : an International Journal of Headache·Clinton G Lauritsen, Stephen D Silberstein
Oct 7, 2018·Acta Neurologica Scandinavica·Vlasta Vukovic Cvetkovic, Rigmor H Jensen
Oct 25, 2017·Neurosurgical Review·Ronald SahyouniHarrison W Lin
May 28, 2019·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Carlos M OrdásJavier Pardo-Moreno
Jan 13, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ilaria Di Donato, Antonio Federico
Jul 17, 2019·Neuromodulation : Journal of the International Neuromodulation Society·Mark HofmeisterFiona Clement
Jul 18, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A V Sergeev
Jul 11, 2019·Headache·Rashmi B Halker SinghMatthew S Robbins
Nov 20, 2018·Cephalalgia : an International Journal of Headache·Denise E ChouJean Schoenen
Aug 1, 2019·Arquivos de neuro-psiquiatria·Fernando KowacsMauro Eduardo Jurno
Apr 26, 2020·Journal of Clinical Medicine·Samar S Ayache, Moussa A Chalah
May 16, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·G R Tabeeva
Jul 29, 2020·Neurología : publicación oficial de la Sociedad Española de Neurología·R BelvísJ M Láinez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.